Taken together, these results indicate an inverse correlation between Fbw7 and LDHA/lactate/miR-223 axis in ABC-DLBCL, which may constitute a promising therapeutic target for ABC-DLBCL patients. This evidence concerns the gene FBXW7 and diffuse large B-cell lymphoma.